Vergoeding 2019-2023 voor ATC-subgroep L04AJ : Complement remmers
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021* | 2022* | 2023* | |
|---|---|---|---|---|---|
| L04AJ01 Eculizumab | 37.946.931 | 35.584.078 | 34.429.032 | 36.541.639 | 28.035.211 |
| L04AJ02 Ravulizumab | . | . | . | . | 2.454.974 |
| L04AJ04 Sutimlimab | . | . | . | . | 55.974 |
| Totaal | 37.946.931 | 35.584.078 | 34.429.032 | 36.541.639 | 30.546.158 |